Concepedia
2
Publications
30
Citations
H-Index
2022
Active since
Affiliations
Yichang Central People's Hospital(Current)
Dailong Li is an author at Yichang Central People's Hospital.
Publications per year
2022–2022
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study
Dailong Li, Lu Xu, Jinxing Ji et al. · Frontiers in Immunology · 2022 · 19 citations · Full text
Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma: A meta-analysis.
Dailong Li, Yaqi Pang, Lu Xu et al. · PubMed · 2022 · 11 citations
Rows per page
1–2 of 2